Report cover image

Europe Pen Needles Market Size, Share & Industry Trends Analysis Report By Type, By Setting, By Application, By Length (8mm, 6mm, 5mm, 10mm, 12mm, and 4mm), By Mode of Purchase, By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Oct 31, 2023
Length 260 Pages
SKU # KBV18339178

Description

Europe Pen Needles Market Size, Share & Industry Trends Analysis Report By Type, By Setting, By Application, By Length (8mm, 6mm, 5mm, 10mm, 12mm, and 4mm), By Mode of Purchase, By Country and Growth Forecast, 2023 - 2030


The Europe Pen Needles Market would witness market growth of 9.0% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 18,166.7 thousand Units, showcasing a growth of 8.9% (2019-2022).

In certain medical conditions, patients may need to self-administer biologic drugs and specialty medications via subcutaneous injection. Pen needles are suitable for these applications because they provide a relatively painless and convenient way to deliver these medications. In some cases, subcutaneous vaccinations may be administered using pen needles, especially for vaccines requiring a subcutaneous administration route. It can be used in various other medical conditions requiring subcutaneous injections. These may include autoimmune diseases, multiple sclerosis, and certain chronic illnesses.

One of the significant advantages of pen needles is their suitability for home healthcare. Patients can easily and safely self-administer medication without the need for healthcare professionals, which improves their quality of life and adherence to treatment plans. The application of pen needles is expanding beyond diabetes management to include various medical conditions, making them a versatile and essential medical device in the healthcare industry. Healthcare professionals and patients need to be well-informed about the proper use of pen needles to ensure effective and safe treatment.

According to Destatis, by the middle of the 2030s, the number of Germans of retirement age (67 or older) will increase by approximately 4 million to at least 20 million. There will be between 5.8 and 6.7 million people aged 80 or older by the middle of the 2030s. Older adults often have more complex healthcare needs, and chronic conditions like diabetes require regular monitoring and treatment. The convenience and ease of use of pen needles are beneficial for seniors who need to self-administer insulin. The aforementioned factors will boost market growth in this region.

The Germany market dominated the Europe Pen Needles Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $203.7 million by 2030. The UK market is showcasing a CAGR of 8.1% during (2023 - 2030). Additionally, The France market would register a CAGR of 9.8% during (2023 - 2030).

Based on Type, the market is segmented into Standard Pen Needles, and Safety Pen Needles. Based on Setting, the market is segmented into Homecare, Hospitals & Clinics, and Others. Based on Application, the market is segmented into Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone, Osteoporosis, and Others. Based on Length, the market is segmented into 8mm, 6mm, 5mm, 10mm, 12mm, and 4mm. Based on Mode of Purchase, the market is segmented into Over the Counter, Prescription-based, Online Purchase, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Embecta Corp., Novo Nordisk A/S, Ypsomed AG, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Limited, Arkray, Inc., UltiMed, Inc. and Allison Medical, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Standard Pen Needles
  • Safety Pen Needles
By Setting (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Homecare
  • Hospitals & Clinics
  • Others
By Application (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Insulin
  • Glucagon-like-Peptide-1 (GLP-1)
  • Growth Hormone
  • Osteoporosis
  • Others
By Length
  • 8mm
  • 6mm
  • 5mm
  • 10mm
  • 12mm
  • 4mm
By Mode of Purchase (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Over the Counter
  • Prescription-based
  • Online Purchase
  • Others
By Country (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Embecta Corp.
  • Novo Nordisk A/S
  • Ypsomed AG
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Owen Mumford Limited
  • Arkray, Inc.
  • UltiMed, Inc.
  • Allison Medical, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

260 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pen Needles Market, by Type
1.4.2 Europe Pen Needles Market, by Setting
1.4.3 Europe Pen Needles Market, by Application
1.4.4 Europe Pen Needles Market, by Length
1.4.5 Europe Pen Needles Market, by Mode of Purchase
1.4.6 Europe Pen Needles Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Market Share Analysis, 2022
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, Feb – 2023, Sep) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Pen Needles Market by Type
5.1 Europe Standard Pen Needles Market by Country
5.2 Europe Safety Pen Needles Market by Country
Chapter 6. Europe Pen Needles Market by Setting
6.1 Europe Homecare Market by Country
6.2 Europe Hospitals & Clinics Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Pen Needles Market by Application
7.1 Europe Insulin Market by Country
7.2 Europe Glucagon-like-Peptide-1 (GLP-1) Market by Country
7.3 Europe Growth Hormone Market by Country
7.4 Europe Osteoporosis Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Pen Needles Market by Length
8.1 Europe 8mm Market by Country
8.2 Europe 6mm Market by Country
8.3 Europe 5mm Market by Country
8.4 Europe 10mm Market by Country
8.5 Europe 12mm Market by Country
8.6 Europe 4mm Market by Country
Chapter 9. Europe Pen Needles Market by Mode of Purchase
9.1 Europe Over the Counter Market by Country
9.2 Europe Prescription-based Market by Country
9.3 Europe Online Purchase Market by Country
9.4 Europe Others Market by Country
Chapter 10. Europe Pen Needles Market by Country
10.1 Germany Pen Needles Market
10.1.1 Germany Pen Needles Market by Type
10.1.2 Germany Pen Needles Market by Setting
10.1.3 Germany Pen Needles Market by Application
10.1.4 Germany Pen Needles Market by Length
10.1.5 Germany Pen Needles Market by Mode of Purchase
10.2 UK Pen Needles Market
10.2.1 UK Pen Needles Market by Type
10.2.2 UK Pen Needles Market by Setting
10.2.3 UK Pen Needles Market by Application
10.2.4 UK Pen Needles Market by Length
10.2.5 UK Pen Needles Market by Mode of Purchase
10.3 France Pen Needles Market
10.3.1 France Pen Needles Market by Type
10.3.2 France Pen Needles Market by Setting
10.3.3 France Pen Needles Market by Application
10.3.4 France Pen Needles Market by Length
10.3.5 France Pen Needles Market by Mode of Purchase
10.4 Russia Pen Needles Market
10.4.1 Russia Pen Needles Market by Type
10.4.2 Russia Pen Needles Market by Setting
10.4.3 Russia Pen Needles Market by Application
10.4.4 Russia Pen Needles Market by Length
10.4.5 Russia Pen Needles Market by Mode of Purchase
10.5 Spain Pen Needles Market
10.5.1 Spain Pen Needles Market by Type
10.5.2 Spain Pen Needles Market by Setting
10.5.3 Spain Pen Needles Market by Application
10.5.4 Spain Pen Needles Market by Length
10.5.5 Spain Pen Needles Market by Mode of Purchase
10.6 Italy Pen Needles Market
10.6.1 Italy Pen Needles Market by Type
10.6.2 Italy Pen Needles Market by Setting
10.6.3 Italy Pen Needles Market by Application
10.6.4 Italy Pen Needles Market by Length
10.6.5 Italy Pen Needles Market by Mode of Purchase
10.7 Rest of Europe Pen Needles Market
10.7.1 Rest of Europe Pen Needles Market by Type
10.7.2 Rest of Europe Pen Needles Market by Setting
10.7.3 Rest of Europe Pen Needles Market by Application
10.7.4 Rest of Europe Pen Needles Market by Length
10.7.5 Rest of Europe Pen Needles Market by Mode of Purchase
Chapter 11. Company Profiles
11.1 Embecta Corp.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Owen Mumford Limited
11.2.1 Company Overview
11.2.2 Recent strategies and developments:
11.2.2.1 Partnerships, Collaborations, and Agreements:
11.2.2.2 Product Launches and Product Expansions:
11.2.3 SWOT Analysis
11.3 Novo Nordisk A/S
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental & Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Acquisition and Mergers:
11.3.5.3 Geographical Expansions:
11.3.6 SWOT Analysis
11.4 Ypsomed AG
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Recent strategies and developments:
11.4.4.1 Partnerships, Collaborations, and Agreements:
11.4.4.2 Product Launches and Product Expansions:
11.4.5 SWOT Analysis
11.5 B. Braun Melsungen AG
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Terumo Corporation
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental and Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Partnerships, Collaborations, and Agreements:
11.6.5.2 Product Launches and Product Expansions:
11.6.6 SWOT Analysis
11.7 Nipro Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expenses
11.7.5 Recent strategies and developments:
11.7.5.1 Partnerships, Collaborations, and Agreements:
11.8 Arkray, Inc.
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 UltiMed, Inc.
11.9.1 Company Overview
11.10. Allison Medical, Inc.
11.10.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us